Form 4: Eastman Chemical Co: Executive Holt Acquires Shares and Stock Options
SEC Form 4 Filing
Adrian James Holt, SVP, Chf HR Ofcr of Eastman Chemical Co, reports acquisition of common stock, stock options, and restricted stock units.
Summary
- On February 20, 2025, Adrian James Holt, SVP, Chf HR Ofcr of Eastman Chemical Co, reported transactions involving the company's securities.
- Holt acquired 2,037 shares of common stock at a price of $101.18 per share.
- Holt also acquired 16,773 employee stock options with an exercise price of $100.56, vesting in three equal installments starting February 20, 2026, and expiring on February 19, 2035.
- Additionally, Holt acquired 3,204 restricted stock units, which will vest and payout in unrestricted shares of Company common stock on February 20, 2028, subject to continued employment.
- Following these transactions, Holt directly owns 16,773 derivative securities and 3,204 restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects standard executive compensation practices and insider trading reporting requirements. The acquisition of shares could be seen as a positive sign, but it's a routine transaction.
Positives
- The acquisition of shares and stock options by a high-ranking executive could be interpreted as a sign of confidence in the company's future performance.
Industry Context
Insider transactions are routinely monitored to gauge executive sentiment and potential future performance of the company. This filing indicates activity by a key executive at Eastman Chemical Co.
Comparison to Industry Standards
- Executive compensation packages including stock options and restricted stock units are common practice among publicly traded companies like Eastman Chemical Co to align management interests with shareholder value.
- Companies such as Dow, BASF, and LyondellBasell also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of executive confidence.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date of transaction: Acquisition of common stock, stock options, and restricted stock units. |
| 02/20/2026 | First vesting date for one-third of the employee stock options. |
| 02/20/2027 | Second vesting date for one-third of the employee stock options. |
| 02/20/2028 | Final vesting date for one-third of the employee stock options and vesting date for the restricted stock units. |
| 02/19/2035 | Expiration date of the employee stock options. |
| 02/24/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.